Similarly, among patients with the GA+AA genotype of the ABCB1 gene, the neutropenia grade showed a significant increase following the second cycle, and the lymphocytopenia grade significantly increased after the fourth cycle compared to pre-treatment levels (p-value < 0.05) (Table 14). The gene discussed is ABCB1; the disease is neutropenia.